Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Second-line step-up therapy vs eltrombopag in children with severe chronic ITP
ChiCTR2100048162Phase 4Not yet recruiting
- Sponsor
- Beijing Children's Hospital
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of eltrombopag in immune thrombocytopenia (ITP) (2 arms), sponsored by Beijing Children's Hospital. Primary endpoint: Response rate. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
eltrombopag
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on ChiCTR2100048162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048162.